NanoRepro AG

NanoRepro AG

Sector: Specialty Hospitals Except Psychiatric Region: Germany

: | Hamburg Stock Exchange: NN6

NanoRepro AG engages in the development, manufacture, and distribution of products in the field of diagnostics and healthcare. Its products include ovulation test, pregnancy test, menopause test, vaginal fungal test, gluten intolerance test, cholesterol test, fertility test for men, and colorectal cancer screening test. The company was founded on January 19, 2006 and is headquartered in Marburg, Germany.

News & Analysis